References
- Ardelt, P., Grunemay, N., Strehl, A., Jilg, C., Miernik, A., Kneitz, B., and Butt, E. (2013). LASP-1, a novel urinary marker for detection of bladder cancer. Urol. Oncol. 31, 1591-1598. https://doi.org/10.1016/j.urolonc.2012.02.002
- Bartenschlager, R., Lohmann, V., and Penin, F. (2013). The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection. Nat. Rev. Microbiol. 11, 482-496. https://doi.org/10.1038/nrmicro3046
- Chew, C.S., Chen, X., Parente, J.A. Jr., Tarrer, S., Okamoto, C., and Qin, H.Y. (2002). Lasp-1 binds to nonmuscle F-actin in vitro and is localized within multiple sites of dynamic actin assembly in vivo. J. Cell Sci. 115, 4787- 4799. https://doi.org/10.1242/jcs.00174
- Giannini, C. and Brechot, C. (2003). Hepatitis C virus biology. Cell Death Differ. 10 Suppl 1, S27-S38. https://doi.org/10.1038/sj.cdd.4401121
- Gitto, S., Gamal, N., and Andreone P. (2017). NS5A inhibitors for the treatment of hepatitis C infection. J. Viral Hepat. 24, 180-186. https://doi.org/10.1111/jvh.12657
- Gottwein, J.M., Pham, L.V., Mikkelsen, L.S., Ghanem, L., Ramirez, S., Scheel, T.K.H., Carlsen, T.H.R., and Bukh, J. (2018). Efficacy of NS5A inhibitors against hepatitis C virus genotypes 1-7 and escape variants. Gastroenterology 154, 1435-1448. https://doi.org/10.1053/j.gastro.2017.12.015
- Grunewald, T. and Butt, E. (2008). The LIM and SH3 domain protein family: structural proteins or signal transducers or both. Mol. Cancer 7, 31. https://doi.org/10.1186/1476-4598-7-31
- Grunewald, T.G., Kammerer, U., Kapp, M., Eck, M., Dietl, J., Butt, E., and Honig, A. (2007). Nuclear localization and cytosolic overexpression of LASP-1 correlates with tumor size and nodal-positivity of human breast carcinoma. BMC Cancer 7, 198. https://doi.org/10.1186/1471-2407-7-198
- Keicher, C., Gambaryan, S., Schulze, E., Marcus, K., Meyer, H.E., and Butt, E. (2004). Phosphorylation of mouse LASP-1 on threonine 156 by cAMPand cGMP-dependent protein kinase. Biochem. Biophys. Res. Commun. 324, 308-316. https://doi.org/10.1016/j.bbrc.2004.08.235
- Larson, S.M. and Davidson, A.R. (2000). The identification of conserved interactions within the SH3 domain by alignment of sequences and structures. Protein Sci. 9, 2170-2180. https://doi.org/10.1110/ps.9.11.2170
- Li, B., Zhuang, L., and Trueb, B. (2004). Zyxin interacts with the SH3 domains of the cytoskeletal proteins LIM-nebulette and Lasp-1. J. Biol. Chem. 279, 20401-20410. https://doi.org/10.1074/jbc.M310304200
- Lim, Y.S. and Hwang, S.B. (2011). Hepatitis C virus NS5A protein interacts with phosphatidylinositol 4-kinase type IIIalpha and regulates viral propagation. J. Biol. Chem. 286, 11290-11298. https://doi.org/10.1074/jbc.M110.194472
- Lim, Y.S., Tran, H.T., Park, S.J., Yim, S.A., and Hwang, S.B. (2011). Peptidylprolyl isomerase Pin1 is a cellular factor required for hepatitis C virus propagation. J. Virol. 85, 8777-8788. https://doi.org/10.1128/JVI.02533-10
- Lindenbach, B.D. and Rice, C.M. (2005). Unravelling hepatitis C virus replication from genome to function. Nature 436, 933-938. https://doi.org/10.1038/nature04077
- Luong, T.T.D., Tran, G.V.Q., Shin, D.J., Lim, Y.S., and Hwang, S.B. (2017). Hepatitis C virus exploits Death receptor 6-mediated signaling pathway to facilitate viral propagation. Sci. Rep. 7, 6445. https://doi.org/10.1038/s41598-017-06740-9
- Mihlan, S., Reiss, C., Thalheimer, P., Herterich, S., Gaetzner, S., Kremerskothen, J., Pavenstadt, H.J., Lewandrowski, U., Sickmann, A., and Butt, E. (2013). Nuclear import of LASP-1 is regulated by phosphorylation and dynamic protein-protein interactions. Oncogene 32, 2107-2113. https://doi.org/10.1038/onc.2012.216
- Nguyen, T.T.T., Park, E.M., Lim, Y.S., and Hwang, S.B. (2018). Nonstructural protein 5A impairs DNA damage repair: implications for hepatitis C virusmediated hepatocarcinogenesis. J. Virol. 92, e00178-18.
- Park, C., Min, S., Park, E.M., Lim, Y.S., Kang, S., Suzuki, T., Shin, E.C., and Hwang, S.B. (2015). Pim kinase interacts with nonstructural 5A protein and regulates hepatitis C virus entry. J. Virol. 89, 10073-10086. https://doi.org/10.1128/JVI.01707-15
- Pawlotsky, J.M., Flisiak, R., Sarin, S.K., Rasenack, J., Piratvisuth, T., Chuang, W.L., Peng, C.Y., Foster, G.R., Shah, S., Wedemeyer, H., et al. (2015). Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection. Hepatology 62, 1013-1023. https://doi.org/10.1002/hep.27960
- Pham, H.T., Nguyen, T.T.T., Nguyen, L.P., Han, S.S., Lim, Y.S., and Hwang, S.B. (2019). Hepatitis C virus downregulates ubiquitin-conjugating enzyme E2S expression to prevent proteasomal degradation of NS5A, leading to host cells more sensitive to DNA damage. J. Virol. 93, e01240-18.
- Saksela, K., Cheng, G., and Baltimore, D. (1995). Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for downregulation of CD4. EMBO J. 14, 484-491. https://doi.org/10.1002/j.1460-2075.1995.tb07024.x
- Tan, S.L., Nakao, H., He, Y., Vijaysri, S., Neddermann, P., Jacobs, B.L., Mayer, B.J., and Katze, M.G. (1999). NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc. Natl. Acad. Sci. U. S. A. 96, 5533-5538. https://doi.org/10.1073/pnas.96.10.5533
- Tang, R., Kong, F., Hu, L., You, H., Zhang, P., Du, W., and Zheng, K. (2012). Role of hepatitis B virus X protein in regulating LIM and SH3 protein 1 (LASP-1) expression to mediate proliferation and migration of hepatoma cells. Virol. J. 9, 163. https://doi.org/10.1186/1743-422X-9-163
- Tomasetto, C., Moog-Lutz, C., Régnier, C.H., Schreiber, V., Basset, P., and Rio, M.C. (1995a). Lasp-1 (MLN 50) defines a new LIM protein subfamily characterized by the association of LIM and SH3 domains. FEBS Lett. 373, 245-249. https://doi.org/10.1016/0014-5793(95)01040-L
- Tomasetto, C., Regnier, C., Moog-Lutz, C., Mattei, M.G., Chenard, M.P., Lidereau, R., Basset, P., and Rio, M.C. (1995b). Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17. Genomics 28, 367-376. https://doi.org/10.1006/geno.1995.1163
- Wang, H., Li, W., Jin, X., Cui, S., and Zhao, L. (2013). LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma. Eur. J. Cancer 49, 974-983. https://doi.org/10.1016/j.ejca.2012.09.032
- Winters, M.J. and Pryciak, P.M. (2005). Interaction with the SH3 domain protein Bem1 regulates signaling by the Saccharomyces cerevisiae p21-activated kinase Ste20. Mol. Cell. Biol. 25, 2177-2190. https://doi.org/10.1128/MCB.25.6.2177-2190.2005
- You, H., Kong, F., Zhou, K., Wei, X., Hu, L., Hu, W., Luo, W., Kou, Y., Liu, X., Chen, X., et al. (2018). HBX protein promotes LASP-1 expression through activation of c-Jun in human hepatoma cells. J. Cell. Physiol. 233, 7279-7291. https://doi.org/10.1002/jcp.26560
- Zhao, L., Wang, H., Liu, C., Liu, Y., Wang, X., Wang, S., Sun, X., Li, J., Deng, Y., Jiang, Y., et al. (2010). Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1. Gut 59, 1226-1235. https://doi.org/10.1136/gut.2009.202739